Feb 25, 2021
Therapeutic Solutions International Spin-Off Campbell Neurosciences Demonstrates Preliminary Efficacy of First Blood-Based Test for Gambling Addiction: Kaihani Score(TM)
Feb 22, 2021
Therapeutic Solutions International Uses StemVacs(TM) Platform to Generate Personalized Adoptive T Cell Therapy Targeting Cancer Stem Cells
Feb 16, 2021
Therapeutic Solutions International Appoints Internationally Renowned Tumor Immunologist Dr. Boris Minev to its Scientific Advisory Board
Feb 10, 2021
Therapeutic Solutions International Acquires Stem Cell Therapy That Successfully Completed FDA Double Blind Placebo Controlled Efficacy Study for Lung Disease
Feb 08, 2021
Therapeutic Solutions International Reports Preliminary Data Suggesting StemVacs Induces Natural Killer Memory to Cancer
Feb 04, 2021
Therapeutic Solutions International Enters into Master Sales Agreement with Community Shield LLC
Feb 01, 2021
Therapeutic Solutions International Reports Therapeutic Efficacy of StemVacs Derived Exosomes in Regression of Glioma
Jan 26, 2021
Therapeutic Solutions International Reports Enhancement of StemVacs Immune Stimulating Activity Using Neuromodulatory Compound Homotaurine
Jan 25, 2021
Therapeutic Solutions International Reports Regression of Glioma, Lung Cancer and Colorectal Cancer using StemVacs in Animal Models
Jan 13, 2021
Therapeutic Solutions International Announces Positive Early Clinical Data from Ongoing Suicidal Ideation Blood Biomarker Clinical Trial with Spinoff Campbell Neurosciences
Jan 05, 2021
Therapeutic Solutions International Reports QuadraMune(TM) Administration Enhances T Cytotoxic Responses in Mouse Model of Adaptive Immunity
Dec 31, 2020
Therapeutic Solutions International Launches Campbell Neurosciences Inc as First Suicide Focused Regenerative Psychiatry Biotechnology Company
Dec 30, 2020
Therapeutic Solutions International Reports QuadraMune(TM) Increases T Cell Immunity in Animal Studies
Dec 21, 2020
Therapeutic Solutions International Files Patent on NeuroLeukin(TM) Personalized Immunotherapy for Opioid Addiction
Dec 17, 2020
Therapeutic Solutions International Files Investigational New Drug Application (IND) with FDA for Treatment of Chronic Traumatic Encephalopathy Using Clinically Validated JadiCell® Universal Donor Stem Cell
Dec 16, 2020
Therapeutic Solutions International Signs Letter of Intent with Premier Adipose Stem Cell Company Synova Life Sciences to File IND for Suicide Prevention
Dec 09, 2020
Therapeutic Solutions International Division of Campbell Neurosciences Files Patent on QuadraMune(TM) for Treatment of Major Depressive Disorder
Dec 01, 2020
Therapeutic Solutions International Announces Positive QuadraMune(TM) Clinical Trial Data
Nov 24, 2020
QuadraMune(TM) Synergizes with Metformin to Stimulate Anti-Viral Defenses in Pilot Clinical Trial
Nov 16, 2020
Therapeutic Solutions International Appoints Famela Ramos as Vice President, Business Development